Annals of neurology
-
Annals of neurology · Sep 2011
Randomized Controlled TrialA randomized, pilot trial of etanercept in dermatomyositis.
The aims of this pilot study were to assess (1) the safety and tolerability of etanercept in dermatomyositis (DM); (2) the feasibility and safety of a forced prednisone taper; and (3) outcome measures, including those recommended by the International Myositis Assessment Clinical Study (IMACS) group. ⋯ The findings of no major safety concerns and a steroid-sparing effect in our study suggest that further investigation of etanercept as a treatment for DM is warranted.